Table 1 Baseline demographics and clinical characteristics of the COVID-19 patients with dementia and matched controls without dementia
Variables | Dementia N = 4051 | Control patientsa N = 1,1511 | p-value2 |
|---|---|---|---|
Age (years) | 82.0 (76.0, 87.0) | 81.0 (75.0, 87.0) | 0.311 |
Men | 166 (41.0%) | 481 (41.8%) | 0.823 |
Comorbidities | |||
Arterial hypertension | 242 (59.8%) | 737 (64.0%) | 0.141 |
Diabetes mellitus | 131 (32.3%) | 382 (33.2%) | 0.803 |
Stroke | 58 (14.3%) | 141 (12.3%) | 0.324 |
Heart failure | 49 (12.1%) | 148 (12.9%) | 0.758 |
Psychiatric disorders | 44 (10.9%) | 96 (8.3%) | 0.154 |
CKD | 42 (10.4%) | 112 (9.7%) | 0.784 |
COPD | 38 (9.4%) | 147 (12.8%) | 0.085 |
CAD | 37 (9.1%) | 125 (10.9%) | 0.377 |
Atrial fibrillation | 34 (8.4%) | 86 (7.5%) | 0.624 |
Cancer | 24 (5.9%) | 66 (5.7%) | 0.985 |
Obesity | 21 (5.2%) | 53 (4.6%) | 0.737 |
Asthma | 14 (3.5%) | 46 (4.0%) | 0.738 |
Rheumatologic disease | 4 (1.0%) | 24 (2.1%) | 0.226 |
Cirrhosis | 3 (0.7%) | 9 (0.8%) | > 0.999 |
Smoking | |||
Current smoking | 12 (3.0%) | 41 (3.6%) | 0.680 |
Previous smoking | 58 (14.3%) | 245 (21.3%) | 0.003 |